Highest rates seen during COVID-19 pandemic versus before pandemic and in females, those aged 14 to 17 and 18 to 22 years
No increased rates of positive M-CHAT-R screening seen for offspring
Although uncommon, contraindicated drug pairs have been prescribed
Minor improvements seen in externalizing problems, anxiety, and attention-deficit/hyperactivity disorder
Findings highlight importance of addressing neurodevelopmental and mental health conditions in this population
Significant increases seen in all subgroups, with greatest increases for girls, American Indian or Alaska Native, and Asian or Pacific Islander preteens
Authors say findings unlikely to be due to common underlying biological mechanisms
Biggest benefits seen for internalizing behavioral issues and prosocial behavior
